| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e76c53448ad20274f0203d87cb26afd3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4035 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 |
| filingDate |
2003-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2b886348a42174a1fd3fecd20de56c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_152e466a72d3e35bdc2363c0b32153ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d800cc0b08a853d12f95898d780f7783
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24f25553515462e54102c7b77cb7bb24 |
| publicationDate |
2005-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20050102080-A |
| titleOfInvention |
Methods and dosage forms for reducing heart attacks in a hypertensive individual with a diuretic or a diuretic and an ace inhibitor combination |
| abstract |
The present invention relates to methods and dosage forms for reducing and / or inhibiting the frequency of cardiovascular diseases including heart disease in patients at risk, such as patients with hypertension. The treatments and dosage forms of the present invention may be used alone or with a thiazid diuretic such as Thalitone® to reduce and / or inhibit the development of cardiovascular diseases such as heart disease or heart failure in hypertensive patients or risk groups. Administration in combination with an ACE inhibitor such as ramipril or ramiprilat. |
| priorityDate |
2002-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |